143 related articles for article (PubMed ID: 35104454)
1. Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death.
Yan B; Ding Z; Zhang W; Cai G; Han H; Ma Y; Cao Y; Wang J; Chen S; Ai Y
Cell Chem Biol; 2022 Jun; 29(6):958-969.e5. PubMed ID: 35104454
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insights into cancer cell killing through interaction of phosphodiesterase 3A and schlafen family member 12.
Wu X; Schnitzler GR; Gao GF; Diamond B; Baker AR; Kaplan B; Williamson K; Westlake L; Lorrey S; Lewis TA; Garvie CW; Lange M; Hayat S; Seidel H; Doench J; Cherniack AD; Kopitz C; Meyerson M; Greulich H
J Biol Chem; 2020 Mar; 295(11):3431-3446. PubMed ID: 32005668
[TBL] [Abstract][Full Text] [Related]
3. Structure of PDE3A-SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells.
Chen J; Liu N; Huang Y; Wang Y; Sun Y; Wu Q; Li D; Gao S; Wang HW; Huang N; Qi X; Wang X
Nat Commun; 2021 Oct; 12(1):6204. PubMed ID: 34707099
[TBL] [Abstract][Full Text] [Related]
4. Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase.
Garvie CW; Wu X; Papanastasiou M; Lee S; Fuller J; Schnitzler GR; Horner SW; Baker A; Zhang T; Mullahoo JP; Westlake L; Hoyt SH; Toetzl M; Ranaghan MJ; de Waal L; McGaunn J; Kaplan B; Piccioni F; Yang X; Lange M; Tersteegen A; Raymond D; Lewis TA; Carr SA; Cherniack AD; Lemke CT; Meyerson M; Greulich H
Nat Commun; 2021 Jul; 12(1):4375. PubMed ID: 34272366
[TBL] [Abstract][Full Text] [Related]
5. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.
de Waal L; Lewis TA; Rees MG; Tsherniak A; Wu X; Choi PS; Gechijian L; Hartigan C; Faloon PW; Hickey MJ; Tolliday N; Carr SA; Clemons PA; Munoz B; Wagner BK; Shamji AF; Koehler AN; Schenone M; Burgin AB; Schreiber SL; Greulich H; Meyerson M
Nat Chem Biol; 2016 Feb; 12(2):102-8. PubMed ID: 26656089
[TBL] [Abstract][Full Text] [Related]
6. An alkaloid initiates phosphodiesterase 3A-schlafen 12 dependent apoptosis without affecting the phosphodiesterase activity.
Ai Y; He H; Chen P; Yan B; Zhang W; Ding Z; Li D; Chen J; Ma Y; Cao Y; Zhu J; Li J; Ou J; Du S; Wang X; Ma J; Gao S; Qi X
Nat Commun; 2020 Jun; 11(1):3236. PubMed ID: 32591543
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST).
Vandenberghe P; Hagué P; Hockman SC; Manganiello VC; Demetter P; Erneux C; Vanderwinden JM
Oncotarget; 2017 Jun; 8(25):41026-41043. PubMed ID: 28454120
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor cells based on Phosphodiesterase 3A expression.
Nazir M; Senkowski W; Nyberg F; Blom K; Edqvist PH; Jarvius M; Andersson C; Gustafsson MG; Nygren P; Larsson R; Fryknäs M
Exp Cell Res; 2017 Dec; 361(2):308-315. PubMed ID: 29107068
[TBL] [Abstract][Full Text] [Related]
9. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
10. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth.
An R; Liu J; He J; Wang F; Zhang Q; Yu Q
Am J Cancer Res; 2019; 9(9):1905-1921. PubMed ID: 31598394
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.
Penmatsa H; Zhang W; Yarlagadda S; Li C; Conoley VG; Yue J; Bahouth SW; Buddington RK; Zhang G; Nelson DJ; Sonecha MD; Manganiello V; Wine JJ; Naren AP
Mol Biol Cell; 2010 Mar; 21(6):1097-110. PubMed ID: 20089840
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase.
Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A
Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149
[TBL] [Abstract][Full Text] [Related]
14. Velcrin-induced selective cleavage of tRNA
Lee S; Hoyt S; Wu X; Garvie C; McGaunn J; Shekhar M; Tötzl M; Rees MG; Cherniack AD; Meyerson M; Greulich H
Nat Chem Biol; 2023 Mar; 19(3):301-310. PubMed ID: 36302897
[TBL] [Abstract][Full Text] [Related]
15. Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium.
Hambleton R; Krall J; Tikishvili E; Honeggar M; Ahmad F; Manganiello VC; Movsesian MA
J Biol Chem; 2005 Nov; 280(47):39168-74. PubMed ID: 16172121
[TBL] [Abstract][Full Text] [Related]
16. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
[TBL] [Abstract][Full Text] [Related]
17. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
Zhang W; Colman RW
Blood; 2007 Sep; 110(5):1475-82. PubMed ID: 17392505
[TBL] [Abstract][Full Text] [Related]
18. High cGMP and low PDE3A activity are associated with oocyte meiotic incompetence.
Gershon E; Maimon I; Galiani D; Elbaz M; Karasenti S; Dekel N
Cell Cycle; 2019 Oct; 18(20):2629-2640. PubMed ID: 31401933
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
Kim YR; Yi M; Cho SA; Kim WY; Min J; Shin JG; Lee SJ
Ann Hum Genet; 2021 Mar; 85(2):80-91. PubMed ID: 33249558
[TBL] [Abstract][Full Text] [Related]
20. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
